Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - Anti-Cancer Agents

Volume 8

eBook: US $79 Special Offer (PDF + Printed Copy): US $134
Printed Copy: US $95
Library License: US $316
ISSN: 2451-8905 (Print)
ISSN: 2215-0803 (Online)
ISBN: 978-1-68108-932-4 (Print)
ISBN: 978-1-68108-931-7 (Online)
Year of Publication: 2021
DOI: 10.2174/97816810893171210801


Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The eighth volume of the book features reviews on these topics:

  • - Key data management elements in clinical trials for oncological therapeutics
  • - Prospects for therapeutic targeting of microRNAs in brain tumors
  • - Breast cancer vaccines: current status and future approach
  • - Desmocollin-3 and cancer
  • - MDM2-p53 antagonists under clinical evaluation: a promising cancer targeted therapy for cancer patients harbouring wild-type tp53
  • - Towards targeted therapy: anticancer agents targeting cell organelle mitochondria
  • - Anticancer therapeutic strategies in gliomas: chemotherapy, immunotherapy, and molecularly targeted therapy in adults

Audience: Pharmaceutical Scientists, Medicinal Chemists, Clinical Oncologists, Researchers in Pre-clinical studies and clinical trials


- Pp. i
Download Free

List of Contributors

- Pp. ii

Download Free

Key Data Management Elements in Clinical Trials for Oncological Therapeutics

- Pp. 1-46 (46)
Daniel Liu*, Hualong Sun, Yan Bo, Joey Wang
View Abstract

Prospects for Therapeutic Targeting of MicroRNAs in Brain Tumors

- Pp. 47-106 (60)
Ilgiz Gareev, Ozal Beylerli*
View Abstract

Breast Cancer Vaccines: Current Status and Future Approach

- Pp. 108-141 (34)
Aytül Gül, Sedef Erkunt Alak, Ceren Gül, Tuğba Karakavuk, Hüseyin Can, Muhammet Karakavuk, Ahmet Efe Köseoğlu, Mert Döşkaya, Aysu Değirmenci Döşkaya, Elif Esin Hameş Tuna, Cemal Ün, Adnan Yüksel Gürüz, Levent Yeniay*
View Abstract

Desmocollin-3 and Cancer

- Pp. 142-163 (22)
Chandreshwar Shukla, Nayan K Jain, Bakulesh Khamar
View Abstract

MDM2-p53 Antagonists Under Clinical Evaluation: A Promising Cancer Targeted Therapy for Cancer Patients Harbouring Wild-Type TP53

- Pp. 164-217 (54)
Maryam Zanjirband*
View Abstract

Towards Targeted Therapy: Anticancer Agents Targeting Cell Organelle Mitochondria

- Pp. 218-282 (65)
Meghana Manjunath, Bibha Choudhary*
View Abstract

Anticancer Therapeutic Strategies in Gliomas: Chemotherapy, Immunotherapy, and Molecularly Targeted Therapy in Adults

- Pp. 283-302 (20)
Xiaoyan Hu*, Kexun Lian, Mengmeng Wang, Xun Zhang*
View Abstract

Subject Index

- Pp. 303-309 (7)

Download Free